Stay updated on FT538 with Daratumumab in AML Clinical Trial
Sign up to get notified when there's something new on the FT538 with Daratumumab in AML Clinical Trial page.

Latest updates to the FT538 with Daratumumab in AML Clinical Trial page
- Check7 days agoChange DetectedA new revision entry v3.6.6 is added to the study's history and the previous revision v3.6.5 is removed. This reflects an update to the page's version history rather than substantive changes to study data or content.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedA new revision entry v3.6.5 was added to the study record history, and the previous revision v3.6.4 was removed.SummaryDifference0.1%

- Check42 days agoChange DetectedA new revision entry v3.6.4 was added to the study record history, and the previous revision v3.6.3 was removed, updating the version history displayed on the page.SummaryDifference0.1%

- Check64 days agoChange DetectedA new latest revision entry v3.6.3 is added to the version history, replacing the previous v3.6.2.SummaryDifference0.1%

- Check71 days agoChange DetectedA new revision tag v3.6.2 was added to the study record history, indicating an update to the record; the older v3.6.0 tag was removed from the history.SummaryDifference0.1%

- Check85 days agoChange DetectedRecruitment status now shows the study is no longer enrolling participants. The record history updates to include revision v3.6.0 and removes the previous revision v3.5.5 entry.SummaryDifference0.4%

Stay in the know with updates to FT538 with Daratumumab in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FT538 with Daratumumab in AML Clinical Trial page.